Results 151 to 160 of about 41,567 (239)

Cholinesterase inhibitors in the treatment of Alzheimer's disease [PDF]

, 2013
Camps Cardenal, Laura, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: a systematic review. [PDF]

BMJ Neurol Open
Cani I, Grotteschi N, Calandra-Buonaura G, Guarino M, Guaraldi P, Giannini G, Baldelli L, Donati M, Cortelli P, Camerlingo MD, Nonino F, Sambati L.   +11 more
europepmc   +1 more source

UV-VIS absorption spectra at high pressure of C-phycocyanin and allophycocyanin from Mastigocladus laminosus [PDF]

, 1991
Fischer, R., Scheer, Hugo, Schneider, Siegfried, Tiltscher, H., Wokusch, T.   +4 more
core  

Cholinesterase inhibitors: drugs looking for a disease?

PLoS Medicine, 2006
Marina Maggini, Nicola Vanacore, Roberto Raschetti   +2 more
doaj   +1 more source

Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors. [PDF]

Drug Healthc Patient Saf
Chikermane SG, Li J, Aparasu RR.
europepmc   +1 more source

The Effect of Cholinesterase Inhibitors on Neurodegeneration in Individuals with Amnestic Mild Cognitive Impairment. [PDF]

Clin Psychopharmacol Neurosci
Byeon G, Byun MS, Yi D, Ahn H, Jung G, Sohn BK, Jung JH, Chang YY, Kim K, Choi H, Kim YH, Kim YK, Kang KM, Sohn CH, Lee DY, KBASE Research Group.   +15 more
europepmc   +1 more source

Exploration of natural products for the development of promising cholinesterase inhibitors in Alzheimer's disease treatment. [PDF]

Heliyon
Nour H, Abchir O, Mounadi N, Samadi A, Salah B, Chtita S.   +5 more
europepmc   +1 more source

The impact of cholinesterase inhibitors on cognitive trajectories in mild cognitive impairment patients based on amyloid beta status. [PDF]

Alzheimers Dement
Liu W, Li Y, Qin W, Wang X, Li W, Li Y, Alzheimer's Disease Neuroimaging Initiative, Jia J.   +7 more
europepmc   +1 more source

Charged Thienobenzo-1,2,3-Triazoles as Especially Potent Non-Selective Cholinesterase Inhibitors: Design, Anti-Inflammatory Activity, and Computational Study. [PDF]

Pharmaceuticals (Basel)
Jelčić A, Raspudić A, Barić D, Ratković A, Šagud I, Pongrac P, Štefok D, Bosnar M, Roca S, Lasić Z, Odak I, Škorić I.   +11 more
europepmc   +1 more source